BiomX (NYSEMKT:PHGE) Trading Down 2%

BiomX Inc. (NYSEMKT:PHGE) fell 2% during mid-day trading on Friday . The company traded as low as $0.28 and last traded at $0.29. 69,414 shares were traded during trading, an increase of 1% from the average session volume of 68,601 shares. The stock had previously closed at $0.30.

BiomX Trading Down 2.0 %

The firm’s 50-day moving average price is $0.32 and its 200-day moving average price is $0.31. The company has a quick ratio of 2.84, a current ratio of 2.84 and a debt-to-equity ratio of 0.51. The company has a market cap of $16.01 million, a P/E ratio of -0.55 and a beta of 1.35.

Institutional Trading of BiomX

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Renaissance Technologies LLC increased its holdings in BiomX by 149.7% during the 2nd quarter. Renaissance Technologies LLC now owns 195,495 shares of the company’s stock worth $70,000 after acquiring an additional 117,195 shares during the period. Susquehanna International Group LLP increased its holdings in BiomX by 372.4% during the 1st quarter. Susquehanna International Group LLP now owns 195,598 shares of the company’s stock worth $60,000 after acquiring an additional 154,189 shares during the period. Millennium Management LLC increased its holdings in BiomX by 208.6% during the 4th quarter. Millennium Management LLC now owns 270,848 shares of the company’s stock worth $51,000 after acquiring an additional 183,091 shares during the period. Finally, Jane Street Group LLC bought a new stake in BiomX during the 1st quarter worth approximately $48,000. Institutional investors own 40.57% of the company’s stock.

BiomX Company Profile

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).